Clinical Trials Directory

Trials / Completed

CompletedNCT03816046

Hyperhydrosis Treatment Using Botulinum Toxin

The Quadrant vs the Six Injection Technique in Primary Focal Hyperhidrosis Using Botulinum Toxin: a Cross-over Clinical Trial.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
15 (actual)
Sponsor
St Joseph University, Beirut, Lebanon · Academic / Other
Sex
Male
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to describe two safe and reproducible techniques for the treatment of hyperhidrosis using botulinum toxin. The same patient will receive two different injection technique in each armpit and will be evaluated subjectively and objectively.

Detailed description

The abobotulinumtoxinA (ABO) will be used in all patients. The ABO will be prepared by adding 4 cc of normal saline to a 500-unit Dysport© (Ipsen Ltd, Berks, UK) vial Preinjection patient pictures will be taken showing the technique used for each armpit. Injection technique: 1. Technique 1 The Quadrant technique: 5 vertical lines and 5 horizontal lines will be draw on the hair bearing area of the armpit amounting to 25 injection points being more concentrated on the center. Each injection consists of 5Units of abobotulinum 2. Technique 2 the six injection technique: will consist on 6 injections in the hair bearing area equally spaced with each consisting of 8units Follow up will be done at 15 days for post injection pictures with iodine starch test A total of 15 male patients will be recruited. And the injection for each armpit in a given patient is randomized.

Conditions

Interventions

TypeNameDescription
DRUGbotulinum toxin Ainjection in hair bearing area of armpits

Timeline

Start date
2018-05-01
Primary completion
2018-07-01
Completion
2019-01-01
First posted
2019-01-25
Last updated
2019-01-25

Locations

1 site across 1 country: Lebanon

Source: ClinicalTrials.gov record NCT03816046. Inclusion in this directory is not an endorsement.

Hyperhydrosis Treatment Using Botulinum Toxin (NCT03816046) · Clinical Trials Directory